To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Neurological Complications After Electrochemotherapy Treatment in the Head and Neck Area
Örebro University, School of Medical Sciences. Örebro University Hospital. Department of Otolaryngology, Örebro University Hospital, Örebro, Sweden.
Department of Otolaryngology, Örebro University Hospital, Örebro, Sweden.
Örebro University, Örebro, Sweden; Department of Neurology, Örebro University Hospital, Örebro, Sweden.
2021 (English)In: Anticancer Research, ISSN 0250-7005, E-ISSN 1791-7530, Vol. 41, no 7, p. 3519-3522Article in journal (Refereed) Published
Abstract [en]

BACKGROUND/AIM: Electrochemotherapy (ECT) is a predominately palliative treatment for cutaneous metastases where an electric field is used to increase the intracellular accumulation of a chemotherapeutic drug (bleomycin or cisplatin). ECT induces a strong anti-vascular effect and endothelial cells seem especially vulnerable. To date, almost no neurological and/or cerebrovascular complications after ECT treatment have been published. In this paper two such cases are reported.

CASE REPORT: A seizure in a man treated with ECT for a basal cell carcinoma in the temporal region and a fatal ischemic stroke in a woman treated for cutaneous metastases in the neck are reported. In both cases a causal relationship to ECT treatment was strongly suspected.

CONCLUSION: ECT in the head and neck can potentially cause severe neurological complications. Ultrasound is recommended for ECT treatment in the neck.

Place, publisher, year, edition, pages
International Institute of Anticancer Research, 2021. Vol. 41, no 7, p. 3519-3522
Keywords [en]
Electrochemotherapy, bleomycin, neurological complication, seizure, stroke
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-93502DOI: 10.21873/anticanres.15139ISI: 000677481500007PubMedID: 34230147Scopus ID: 2-s2.0-85109316557OAI: oai:DiVA.org:oru-93502DiVA, id: diva2:1584043
Available from: 2021-08-10 Created: 2021-08-10 Last updated: 2021-08-10Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Landström, Fredrik

Search in DiVA

By author/editor
Landström, Fredrik
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Anticancer Research
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 12 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf